The global bacteriophage therapy market size is valued at USD 1,242.0 million in 2021, growing at a CAGR of 3.5% during the forecast period 2022-2028. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Bacteriophage Therapy Market: By Type (Lytic, Lysogenic), By Application (Diagnostic, Antimicrobial Drug Discovery, Veterinary Medicines, Others), End-User (Hospitals & Clinics, Academic Research Organizations & Institutes, Others) - Global/Region/Country Forecast to 2028”.

View detailed report description at

Increase in the incidence of antibiotic-resistant bacteria reinforces the use of Bacteriophage Therapy:
Phages also known as bacteriophages are viruses, which attack and goal bacteria completely. These viruses are the most regular biological entities able to fight and kill multi-drug resistance bacteria. Phages are used to eradicate bacteria when all other antibiotics are not able to treat disease. Phases eradicate bacteria, which cause the infectious disease enabling medical experts to save a life. Bacteriophages are used as a possible antibiotic option. In Bacteriophage Therapy, viruses are used for adding their genetic material into bacteria and develop making use of their host machinery. Such phage therapy is used in the patient’s body for treating or preventing bacterial diseases.  Bacteriophage therapy has significance in the technological research and molecular biology. Such characteristics widen the likelihood of medication development. Different development and research activities in the bacteriophages therapy market are supporting to the expansion of the industry.

There are several factors driving the bacteriophage therapy market over the prediction time span such as a huge array of applications with bacteriophage therapeutics, FDA approval for bacteriophage therapies, increase in funds from both private and public sectors for bacteriophage therapy research, strict rules for the antibiotics use and capable pipeline drugs under different stages of clinical attempts. In addition, growing incidence of antibiotic-resistant bacteria reinforces the bacteriophage therapy use.  One of the most common uses of bacteriophage therapy is used for treating of pathogenic bacterial infections with viruses. These are more particular as compared to bacteria and never cause injury to host organisms and advantageous bacteria like gut flora. Bacteriophages are applied in particular areas for eliminating the bacteria. Key benefits of bacteriophages over antibiotics include they are rapidly choosing the new phages, very specific, cause few side effects and replicate at the infection site. Rectal, local applications, intrapleural and intravenous injections are used to administer the bacteriophages.

Request sample report at

North America is anticipated to obtain the biggest share in the global bacteriophage therapy market among other regions due to the partnerships and acquisitions by key industries working in the region. China is projected to lead the bcteriophages therapy market with major growth in the Asia-Pacific market due to the growing investment in pioneering R&D for drug products.


There are leading players operating in the bacteriophage therapy market such as Agamatrix, Companion Medical, Validic, Propeller Health and ZTE Corporation.

Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: | D U N S® Number: 852781747